rs145552478

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_030928.4(CDT1):​c.613G>A​(p.Gly205Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00392 in 1,612,904 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0028 ( 5 hom., cov: 33)
Exomes 𝑓: 0.0040 ( 11 hom. )

Consequence

CDT1
NM_030928.4 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 1.84

Publications

4 publications found
Variant links:
Genes affected
CDT1 (HGNC:24576): (chromatin licensing and DNA replication factor 1) The protein encoded by this gene is involved in the formation of the pre-replication complex that is necessary for DNA replication. The encoded protein can bind geminin, which prevents replication and may function to prevent this protein from initiating replication at inappropriate origins. Phosphorylation of this protein by cyclin A-dependent kinases results in degradation of the protein. [provided by RefSeq, Mar 2011]
CDT1 Gene-Disease associations (from GenCC):
  • Meier-Gorlin syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Meier-Gorlin syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014092654).
BP6
Variant 16-88805564-G-A is Benign according to our data. Variant chr16-88805564-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 434673.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00282 (429/152338) while in subpopulation NFE AF = 0.00475 (323/68024). AF 95% confidence interval is 0.00432. There are 5 homozygotes in GnomAd4. There are 195 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDT1NM_030928.4 linkc.613G>A p.Gly205Ser missense_variant Exon 4 of 10 ENST00000301019.9 NP_112190.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDT1ENST00000301019.9 linkc.613G>A p.Gly205Ser missense_variant Exon 4 of 10 1 NM_030928.4 ENSP00000301019.4
CDT1ENST00000562747.1 linkn.319G>A non_coding_transcript_exon_variant Exon 3 of 5 2
CDT1ENST00000569140.1 linkc.-206G>A upstream_gene_variant 3 ENSP00000456926.1

Frequencies

GnomAD3 genomes
AF:
0.00282
AC:
429
AN:
152220
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000470
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00475
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00237
AC:
592
AN:
250030
AF XY:
0.00227
show subpopulations
Gnomad AFR exome
AF:
0.000744
Gnomad AMR exome
AF:
0.000984
Gnomad ASJ exome
AF:
0.00229
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000416
Gnomad NFE exome
AF:
0.00437
Gnomad OTH exome
AF:
0.00344
GnomAD4 exome
AF:
0.00403
AC:
5886
AN:
1460566
Hom.:
11
Cov.:
32
AF XY:
0.00388
AC XY:
2816
AN XY:
726596
show subpopulations
African (AFR)
AF:
0.000597
AC:
20
AN:
33476
American (AMR)
AF:
0.00105
AC:
47
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00245
AC:
64
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86256
European-Finnish (FIN)
AF:
0.000594
AC:
31
AN:
52204
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00492
AC:
5466
AN:
1111944
Other (OTH)
AF:
0.00409
AC:
247
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
418
836
1254
1672
2090
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00282
AC:
429
AN:
152338
Hom.:
5
Cov.:
33
AF XY:
0.00262
AC XY:
195
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.000722
AC:
30
AN:
41578
American (AMR)
AF:
0.00314
AC:
48
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.000470
AC:
5
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00475
AC:
323
AN:
68024
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00459
Hom.:
4
Bravo
AF:
0.00294
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.00488
AC:
42
ExAC
AF:
0.00234
AC:
284
EpiCase
AF:
0.00469
EpiControl
AF:
0.00516

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CDT1: BP4, BS2 -

Meier-Gorlin syndrome 4 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 08, 2021
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CDT1-related disorder Benign:1
Oct 17, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
17
DANN
Uncertain
1.0
DEOGEN2
Benign
0.049
T
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.15
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.82
T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.014
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.99
L
PhyloP100
1.8
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.8
N
REVEL
Benign
0.15
Sift
Benign
0.18
T
Sift4G
Benign
0.13
T
Polyphen
0.94
P
Vest4
0.10
MVP
0.57
MPC
0.015
ClinPred
0.032
T
GERP RS
0.037
PromoterAI
0.024
Neutral
Varity_R
0.27
gMVP
0.50
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145552478; hg19: chr16-88871972; COSMIC: COSV99039903; COSMIC: COSV99039903; API